Pharmacology, Toxicology and Pharmaceutical Science
Chronic Kidney Failure
100%
Hemodialysis
95%
All Cause Mortality
24%
Diabetes Mellitus
22%
Mouse
22%
Creatinine
20%
Ciclosporin
20%
Indican
18%
Placebo
17%
Finerenone
17%
End Stage Renal Disease
16%
Kidney Disease
16%
Non Insulin Dependent Diabetes Mellitus
15%
Acute Kidney Failure
15%
Sulfate
14%
Adverse Event
13%
Uremic Toxin
13%
Disease
12%
Cardiovascular Mortality
12%
Cohort Study
12%
Kidney Failure
12%
Parathyroid Hormone
12%
Peritonitis
11%
Prevalence
10%
Disease Exacerbation
9%
Serum Albumin
9%
Cardiovascular Disease
9%
Inflammation
9%
Renin
9%
Erythropoietin
9%
Angiotensin
8%
Cresol
8%
Retrospective Study
8%
Dialysis Fluid
8%
Malignant Neoplasm
8%
Prospective Cohort Study
7%
Nitric Oxide
7%
Thrombosis
7%
Anemia
7%
Kidney Polycystic Disease
7%
Rapamycin
7%
Infection
7%
Hyperkalemia
7%
Hepatitis C Virus
6%
Randomized Controlled Trial
6%
Hyperphosphatemia
6%
Kidney Fibrosis
6%
Mammalian Target of Rapamycin Inhibitor
6%
Coronary Artery Disease
6%
Replacement Therapy
6%
Medicine and Dentistry
Chronic Kidney Disease
65%
Hemodialysis
50%
Acute Kidney Injury
24%
Peritoneal Dialysis
23%
End Stage Renal Disease
21%
Nephropathy
18%
Leptospira
15%
All Cause Mortality
15%
Diabetes Mellitus
14%
Weil's Disease
14%
Renal Failure
13%
Kidney Graft
12%
Kidney Transplantation
12%
Cohort Analysis
12%
Proportional Hazards Model
11%
Prevalence
10%
Outer Membrane Protein
10%
Isotopes of Calcium
10%
Parathyroid Hormone
9%
Hazard Ratio
9%
Polycystic Kidney Disease
9%
Cyclosporine
9%
Meta-Analysis
8%
Kidney Function
8%
Anemia
8%
Disease
8%
Interstitial Nephritis
8%
Erythropoietin
8%
Toll Like Receptor 2
7%
Nephrology
7%
Biological Marker
7%
Infection
7%
Rapamycin
7%
Mammalian Target of Rapamycin Inhibitor
7%
Cardiovascular Mortality
7%
Renal Replacement Therapy
6%
Peritonitis
6%
Kidney Injury
6%
Serotype
6%
Continuous Ambulatory Peritoneal Dialysis
6%
Heart Ventricle Remodeling
6%
Cardiovascular Disease
6%
Indican
6%
Diabetes
6%
Odds Ratio
6%
Gene Expression
6%
Mortality Rate
6%
Retrospective Cohort Study
5%
Allograft
5%
Glomerular Filtration Rate
5%
Biochemistry, Genetics and Molecular Biology
Hemodialysis
67%
Cohort Study
15%
All Cause Mortality
15%
Parathyroid Hormone
15%
Kidney Function
13%
Glomerulus Filtration
12%
Prevalence
11%
Erythropoietin
10%
Comorbidity
9%
Peritoneal Dialysis
9%
Cardiovascular Mortality
7%
Mouse
7%
Continuous Ambulatory Peritoneal Dialysis
6%
Calcium Blood Level
6%
Genetic Divergence
6%
Glycemic Control
5%
Single-Nucleotide Polymorphism
5%
Observational Study
5%
Case-Control Study
5%